These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9121264)

  • 21. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.
    Kenck C; Wilhelm M; Bugert P; Staehler G; Kovacs G
    J Pathol; 1996 Jun; 179(2):157-61. PubMed ID: 8758207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetics of renal cell carcinoma.
    Wagner JR; Linehan WM
    Semin Urol Oncol; 1996 Nov; 14(4):244-9. PubMed ID: 8946625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas.
    Lubinski J; Hadaczek P; Podolski J; Toloczko A; Sikorski A; McCue P; Druck T; Huebner K
    Cancer Res; 1994 Jul; 54(14):3710-3. PubMed ID: 8033088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for renal carcinoma associated mutations in the von Hippel-Lindau tumor suppressor gene by temperature gradient gel electrophoresis.
    Wenzel M; Enczmann J; Uhrberg M; Hernández A; Wiese U; Ackermann R; Schmitz-Draeger B; Ebert T; Wernet P
    Electrophoresis; 1997 Jan; 18(1):45-51. PubMed ID: 9059819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cancer genetics: von Hippel Lindau and other syndromes.
    Fleming S
    Int J Dev Biol; 1999; 43(5):469-71. PubMed ID: 10535326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
    Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Farmer GE; Lamiell JM; Haines J; Yuen JW; Collins D; Majoor-Krakauer D
    Nature; 1988 Mar; 332(6161):268-9. PubMed ID: 2894613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collecting duct carcinomas of the kidney: a comparative loss of heterozygosity study with clear cell renal cell carcinoma.
    Fogt F; Zhuang Z; Linehan WM; Merino MJ
    Oncol Rep; 1998; 5(4):923-6. PubMed ID: 9625847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synchronous and multiple renal cell carcinoma, clear cell and papillary: An approach to clinically significant genetic abnormalities.
    Cifuentes-C L; Martinez CH; Garcia-Perdomo HA
    Int Braz J Urol; 2020; 46(2):287-293. PubMed ID: 32022527
    [No Abstract]   [Full Text] [Related]  

  • 29. Familial renal cell carcinoma: review of recent molecular genetics.
    Yao M; Shuin T
    Int J Urol; 1995 May; 2(2):61-70. PubMed ID: 7553290
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular genetics of kidney cancer.
    Zimmer M; Iliopoulos O
    Cancer Treat Res; 2003; 116():3-27. PubMed ID: 14650823
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Percutaneous radio frequency ablation of small renal tumors: initial results.
    Ogan K; Cadeddu JA
    J Urol; 2002 Aug; 168(2):660; author reply 660-1. PubMed ID: 12131338
    [No Abstract]   [Full Text] [Related]  

  • 32. Familial association of supernumerary nipple with renal cancer.
    Mehes K
    Cancer Genet Cytogenet; 1996 Feb; 86(2):129-30. PubMed ID: 8603338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Hereditary papillary renal cell carcinoma: clinical studies in 10 families.
    Zbar B; Linehan WM
    J Urol; 1996 Nov; 156(5):1781. PubMed ID: 8863608
    [No Abstract]   [Full Text] [Related]  

  • 34. Familial renal cell cancer appears to have a recessive component.
    Hemminki K; Li X
    J Med Genet; 2004 May; 41(5):e58. PubMed ID: 15121786
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Familial renal cell carcinoma: hereditary or coincidental?
    Haddad FS
    J Urol; 1991 Jul; 146(1):168. PubMed ID: 2056584
    [No Abstract]   [Full Text] [Related]  

  • 36. Familial clustering of sporadic kidney cancer: insufficient evidence to recommend routine screening in unaffected kin.
    Smaldone MC; Giri VN; Uzzo RG
    Eur Urol; 2011 Nov; 60(5):994-5; discussion 995-7. PubMed ID: 21741161
    [No Abstract]   [Full Text] [Related]  

  • 37. The association of W17 with familial renal cell carcinoma.
    Braun WE; Strimlan CV; Negron AG; Straffon RA; Zachary AA; Bartee SL; Grecek DR
    Tissue Antigens; 1975 Aug; 6(2):101-4. PubMed ID: 1179406
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal carcinoma in mother and daughter.
    Steinberg SM; Brodovsky HS; Goepp CE
    Cancer; 1972 Jan; 29(1):222-5. PubMed ID: 5007383
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal carcinoma with a strong family history.
    Mathieson PW
    Br J Urol; 1986 Aug; 58(4):458-9. PubMed ID: 3756419
    [No Abstract]   [Full Text] [Related]  

  • 40. PBRM1 loss redirects chromatin remodelling complex to recruit oncogenic factors.
    Nat Cell Biol; 2023 Jun; 25(6):808-809. PubMed ID: 37169881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.